Shopping Cart
- Remove All
- Your shopping cart is currently empty
IDO1/TDO-IN-4 is a novel dual inhibitor of IDO1/TDO with antidepressant activity, forming hydrogen bonds with IDO1 and π-π stacking interactions with TDO. IDO1/TDO-IN-4 rescues lipopolysaccharide-induced depressive-like behaviors in mice, used for cancer and Alzheimer's disease research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $59 | In Stock | |
5 mg | $128 | 5 days |
Description | IDO1/TDO-IN-4 is a novel dual inhibitor of IDO1/TDO with antidepressant activity, forming hydrogen bonds with IDO1 and π-π stacking interactions with TDO. IDO1/TDO-IN-4 rescues lipopolysaccharide-induced depressive-like behaviors in mice, used for cancer and Alzheimer's disease research. |
Targets&IC50 | TDO:1.15 μM, IDO1:3.53 μM |
In vitro | IDO1/TDO-IN-4 has dual inhibition on IDO1 and TDO with IC50 values of 3.53 μM and 1.15 μM, respectively. IDO1/TDO-IN-4 (0-2 μM, 1 h) can inhibit the activity of BV2 microglia induced by LPS. [1] |
In vivo | IDO1/TDO-IN-4 (20 mg/kg) also salvaged lipopolysaccharids-induced depression-like behavior IN mice. [1] |
Molecular Weight | 234.26 |
Formula | C14H10N4 |
Cas No. | 461424-21-5 |
Smiles | N1=CNC(=C1)C=2N=CC=C3C4=CC=CC=C4NC23 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (426.88 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.